Glycemic Control Rate of T2DM Outpatients in China: A Multi-Center Survey

Background Type 2 diabetes mellitus (T2DM)-associated mortality and morbidity are strongly dependent on glycemic control. With T2DM prevalence increasing in China, we aimed to assess glycemic control rates in Chinese T2DM outpatients. Material/Methods A total of 9065 adult T2DM outpatients (5035 men) were assessed in 26 Chinese medical centers between August 2010 and April 2012. Patients were stratified according to BMI (kg/m2): <24, 24–28, and >28. Successful glycemic control was defined as glycated hemoglobin A1c (HbA1c) ≤7% or fasting plasma glucose (FPG) <7.0 mmol/L. Results Among the participants included in this study, 2939 had BMI <24, 3361 had BMI of 24–28, and 2764 had BMI >28. The glycemic control rate was only 32.6%, and the triple control rate for glycemia, blood pressure, and lipidemia was only 11.2%. Glycemic control rates by BMI group were 33.7% (<24), 33.8% (24–28), and 30.2% (>28) (p=0.005), and corresponding incidences of cardiovascular diseases (CVD) were 12.2%, 15.7%, and 15.9% (p<0.001). Multivariate logistic regression analysis demonstrated that older age (p<0.001), higher BMI (p=0.026), larger waist circumference (p<0.001), less education (p<0.001), and recent diagnosis (p<0.001) were independent risk factors for poor glycemic control. Conclusions The T2DM glycemic control rate in China is currently low, especially in older obese patients with poor education and recent diagnosis.

[1]  C. Chen.  Overview of obesity in Mainland China , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[2]  M. C. Samaan,et al.  Management of Pediatric and Adolescent Type 2 Diabetes , 2013, International journal of pediatrics.

[3]  L. V. Van Gaal,et al.  Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes. , 2014, The lancet. Diabetes & endocrinology.

[4]  M. Webster.  Clinical practice and implications of recent diabetes trials , 2011, Current opinion in cardiology.

[5]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[6]  L. Yao,et al.  Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease , 2014, Journal of immunology research.

[7]  W. A. Blumentals,et al.  Obesity in hospitalized type 2 diabetes patients: A descriptive study , 2013, Medical science monitor : international medical journal of experimental and clinical research.

[8]  Li Yan,et al.  Determinants for inadequate glycaemic control in Chinese patients with mild-to-moderate type 2 diabetes on oral antidiabetic drugs alone. , 2011, Chinese medical journal.

[9]  R. Eckel,et al.  Obesity and type 2 diabetes: what can be unified and what needs to be individualized? , 2011, The Journal of clinical endocrinology and metabolism.

[10]  Ambady Ramachandran,et al.  Obesity in Asia – is it different from rest of the world , 2012, Diabetes/metabolism research and reviews.

[11]  N. Suksomboon,et al.  Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. , 2009, Diabetes technology & therapeutics.

[12]  D. Shoback,et al.  Greenspan's Basic & Clinical Endocrinology , 2007 .

[13]  Vishal Sharma,et al.  Diabetes in Asia , 2010, The Lancet.

[14]  K. Strojek,et al.  Self-monitoring of blood glucose in treatment of type 2 diabetes. , 2009, Diabetes research and clinical practice.

[15]  T. Yoo,et al.  Good Glycemic Control Is Associated with Better Survival in Diabetic Patients on Peritoneal Dialysis: A Prospective Observational Study , 2012, PloS one.

[16]  J. R. Scotti,et al.  Available From , 1973 .

[17]  H. Fukuta,et al.  Effects of acupuncture stimulation on blood glucose concentration in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat, an animal model for type-2 diabetes mellitus , 2014, Medical science monitor basic research.

[18]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[19]  [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. , 2007, Zhonghua xin xue guan bing za zhi.

[20]  P. Zimmet,et al.  Diagnosis and classification of diabetes mellitus , 2002 .

[21]  Michael W. Schwartz,et al.  Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized? , 2011, Diabetes Care.

[22]  Y. Farag,et al.  Diabesity: an overview of a rising epidemic. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  Bei-fan Zhou.  [Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population]. , 2002, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[24]  A. Juozulynas,et al.  Quality of life in relation to social and disease factors in patients with type 2 diabetes in Lithuania , 2013, Medical science monitor : international medical journal of experimental and clinical research.

[25]  De-Min Yu,et al.  Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables , 2013, BMC Public Health.

[26]  Catherine Whitmore.  Type 2 diabetes and obesity in adults. , 2010, British journal of nursing.

[27]  Walter C Willett,et al.  Dietary fats and prevention of type 2 diabetes. , 2009, Progress in lipid research.

[28]  Li-sheng Liu,et al.  [2010 Chinese guidelines for the management of hypertension]. , 2011, Zhonghua xin xue guan bing za zhi.

[29]  John Wilding,et al.  Obesity and Diabetes , 2010, Experimental and Clinical Endocrinology & Diabetes.

[30]  R. Urban,et al.  Management of blood glucose in type 2 diabetes mellitus. , 2009, American family physician.

[31]  J. Chan,et al.  Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States , 2013, Annals of the New York Academy of Sciences.